NEW YORK (Reuters) - Drugmakers are building safety "switches" that can be used to turn off powerful cancer therapies known as CAR T cells when they cause life-threatening inflammation or attack ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback